Cargando…

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Mutations in the BRCA1 and BRCA2 genes are known risk factors and drivers of breast and ovarian cancers. So far, few studies have been focused on understanding the differences in transcriptome and functional landscapes associated with the disease (breast vs. ovarian cancers), gene (BRCA1 vs. BRCA2),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arakelyan, Arsen, Melkonyan, Ani, Hakobyan, Siras, Boyarskih, Uljana, Simonyan, Arman, Nersisyan, Lilit, Nikoghosyan, Maria, Filipenko, Maxim, Binder, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865215/ https://www.ncbi.nlm.nih.gov/pubmed/33525353 http://dx.doi.org/10.3390/ijms22031266

Ejemplares similares

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

PSF toolkit: an R package for pathway curation and topology-aware analysis
por: Hakobyan, Siras, et al.
Publicado: (2023)

Telomere Maintenance Pathway Activity Analysis Enables Tissue- and Gene-Level Inferences
por: Nersisyan, Lilit, et al.
Publicado: (2021)

WGS-based telomere length analysis in Dutch family trios implicates stronger maternal inheritance and a role for RRM1 gene
por: Nersisyan, Lilit, et al.
Publicado: (2019)

Population Levels Assessment of the Distribution of Disease-Associated Variants With Emphasis on Armenians – A Machine Learning Approach
por: Nikoghosyan, Maria, et al.
Publicado: (2019)

Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer
por: Boyarskikh, Ulyana A., et al.
Publicado: (2020)

Footprints of Sepsis Framed Within Community Acquired Pneumonia in the Blood Transcriptome
por: Hopp, Lydia, et al.
Publicado: (2018)

A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy
por: Hakobyan, Siras, et al.
Publicado: (2021)

Computel: Computation of Mean Telomere Length from Whole-Genome Next-Generation Sequencing Data
por: Nersisyan, Lilit, et al.
Publicado: (2015)

Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers
por: Hopp, Lydia, et al.
Publicado: (2015)

Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
por: Arakelyan, Arsen, et al.
Publicado: (2016)

Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles
por: Arakelyan, Arsen, et al.
Publicado: (2017)

CyKEGGParser: tailoring KEGG pathways to fit into systems biology analysis workflows
por: Nersisyan, Lilit, et al.
Publicado: (2014)

Characterization of BRCA1/2 mutations in patients with family history of breast cancer in Armenia
por: Atshemyan, Sofi, et al.
Publicado: (2017)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

Telomere Length Maintenance and Its Transcriptional Regulation in Lynch Syndrome and Sporadic Colorectal Carcinoma
por: Nersisyan, Lilit, et al.
Publicado: (2019)

Correction: Long-term environmental metal exposure is associated with hypomethylation of CpG sites in NFKB1 and other genes related to oncogenesis
por: Stepanyan, Ani, et al.
Publicado: (2023)

Long-term environmental metal exposure is associated with hypomethylation of CpG sites in NFKB1 and other genes related to oncogenesis
por: Stepanyan, Ani, et al.
Publicado: (2023)

The Evolving Faces of the SARS-CoV-2 Genome
por: Schmidt, Maria, et al.
Publicado: (2021)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
por: Savanevich, Alena, et al.
Publicado: (2021)

Molecular Analysis of SARS-CoV-2 Lineages in Armenia
por: Avetyan, Diana, et al.
Publicado: (2022)

High-Resolution Cartography of the Transcriptome and Methylome Landscapes of Diffuse Gliomas
por: Willscher, Edith, et al.
Publicado: (2021)

BRCA mutations in the manifestation and treatment of ovarian cancer
por: Pan, Zimin, et al.
Publicado: (2017)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010)

BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2010)

Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland
por: Jasiewicz, Andrzej, et al.
Publicado: (2022)

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples
por: Badoer, Cindy, et al.
Publicado: (2016)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
por: Yazici, H, et al.
Publicado: (2000)

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
por: Whittemore, A S, et al.
Publicado: (2004)

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
por: Claes, K, et al.
Publicado: (2004)

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors
por: O’Sullivan, Ciara C., et al.
Publicado: (2014)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
por: Ashour, Mohamed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lp7fld9e2ssnlmlvtogiipn3m1